The Exciting New Field of HER2-Low Breast Cancer Treatment
 

Don't know if I agree with the word "exciting" in the title, though the article has useful info particularly if one is not up-to-date in various aspects of her2 med. A bit more info on Zenocutuzumab, a hint that it might work after CDK4/6 med.

Nguyen

The Exciting New Field of HER2-Low Breast Cancer Treatment

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957750/